US Stock MarketDetailed Quotes

Ironwood Pharmaceuticals (IRWD)

Watchlist
  • 4.520
  • -0.020-0.44%
Close Jan 15 16:00 ET
  • 4.529
  • +0.009+0.20%
Post 19:27 ET
735.31MMarket Cap25.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ironwood Pharmaceuticals (IRWD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
33.26%122.06M
-9.70%85.24M
-45.05%41.14M
-20.63%351.41M
-22.98%90.55M
-19.47%91.59M
-12.09%94.4M
-28.05%74.88M
7.83%442.74M
9.66%117.55M
Operating revenue
33.26%122.06M
-9.70%85.24M
-45.05%41.14M
-20.63%351.41M
-22.98%90.55M
-19.47%91.59M
-12.09%94.4M
-28.05%74.88M
7.83%442.74M
9.66%117.55M
Cost of revenue
Gross profit
Operating expense
-32.70%44.38M
-40.36%40.17M
-18.49%51.69M
-6.82%255.69M
-20.66%58.98M
-4.48%65.94M
-22.64%67.35M
44.25%63.42M
71.22%274.4M
91.43%74.34M
Selling and administrative expenses
-39.33%21.91M
-54.56%16.8M
-35.49%24.26M
-8.87%144.27M
-13.13%33.59M
0.19%36.11M
-29.57%36.96M
20.85%37.61M
36.48%158.31M
36.20%38.67M
Research and development costs
-24.67%22.47M
-23.08%23.37M
6.26%27.43M
-4.02%111.42M
-28.83%25.39M
-9.57%29.83M
-12.11%30.39M
100.94%25.82M
162.25%116.09M
241.53%35.68M
Operating profit
202.84%77.68M
66.66%45.07M
-192.07%-10.55M
-43.14%95.72M
-26.95%31.56M
-42.62%25.65M
33.08%27.04M
-80.94%11.46M
-32.76%168.34M
-36.79%43.21M
Net non-operating interest income expense
9.23%-7.5M
-23.55%-7.54M
-18.79%-7.2M
-974.72%-28.57M
-12.55%-8.14M
-2.18%-8.27M
-188.20%-6.1M
-205.52%-6.06M
-239.67%-2.66M
-284.41%-7.23M
Non-operating interest income
-19.27%930K
-40.25%818K
-25.66%869K
-76.45%4.47M
-34.84%778K
-34.10%1.15M
-84.37%1.37M
-83.92%1.17M
99.67%18.97M
-78.08%1.19M
Non-operating interest expense
-10.46%8.43M
11.86%8.36M
15.77%7.9M
52.73%33.03M
5.83%8.91M
-4.27%9.42M
305.98%7.47M
506.49%6.82M
184.67%21.63M
182.75%8.42M
Total other finance cost
----
----
-58.09%171K
----
----
----
----
1.49%408K
----
----
Other net income (expense)
-13,400.00%-2.16M
113.98%289K
-4,138.44%-18.52M
99.82%-1.95M
110.09%567K
99.66%-16K
99.81%-2.07M
-2,400.00%-437K
-612,048.90%-1.11B
-31,127.78%-5.62M
Gain on sale of security
----
----
----
----
----
----
----
----
-89.56%19K
--0
Special income (charges)
-13,650.00%-2.2M
112.09%250K
-4,146.91%-18.56M
99.77%-2.59M
98.70%-73K
99.66%-16K
99.81%-2.07M
---437K
---1.11B
---5.62M
-Less：Restructuring and merger&acquisition
13,650.00%2.2M
-112.09%-250K
4,146.91%18.56M
-85.84%2.59M
-88.24%73K
-99.66%16K
-84.11%2.07M
--437K
--18.32M
--621K
-Less:Other special charges
----
----
----
----
----
----
----
----
--1.1B
--5M
Other non- operating income (expenses)
--40K
--39K
--37K
--640K
----
----
----
----
----
----
Income before tax
291.62%68.02M
100.37%37.82M
-831.59%-36.27M
106.88%65.2M
-20.97%24M
-45.61%17.37M
101.75%18.88M
-92.47%4.96M
-475.59%-948.07M
-57.99%30.36M
Income tax
103.60%27.94M
-27.93%14.22M
-87.79%1.11M
-22.96%64.32M
-32.29%21.74M
-23.68%13.72M
48.88%19.74M
-54.73%9.12M
7.93%83.49M
37.21%32.11M
Net income
999.29%40.08M
2,844.07%23.6M
-798.27%-37.39M
100.09%880K
229.28%2.26M
-73.86%3.65M
99.92%-860K
-109.10%-4.16M
-689.24%-1.03B
-103.57%-1.75M
Net income continuous Operations
999.29%40.08M
2,844.07%23.6M
-798.27%-37.39M
100.09%880K
229.28%2.26M
-73.86%3.65M
99.92%-860K
-109.10%-4.16M
-689.24%-1.03B
-103.57%-1.75M
Minority interest income
0
0
0
0
-29.32M
-658K
Net income attributable to the parent company
999.29%40.08M
2,844.07%23.6M
-798.27%-37.39M
100.09%880K
307.54%2.26M
-76.20%3.65M
99.92%-860K
-109.10%-4.16M
-672.50%-1B
-102.22%-1.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
999.29%40.08M
2,844.07%23.6M
-798.27%-37.39M
100.09%880K
307.54%2.26M
-76.20%3.65M
99.92%-860K
-109.10%-4.16M
-672.50%-1B
-102.22%-1.09M
Basic earnings per share
1,150.00%0.25
1,600.00%0.15
-666.67%-0.23
100.16%0.01
300.00%0.02
-80.00%0.02
99.85%-0.01
-110.00%-0.03
-670.80%-6.45
-103.13%-0.01
Diluted earnings per share
1,050.00%0.23
1,500.00%0.14
-666.67%-0.23
100.16%0.01
300.00%0.02
-77.78%0.02
99.85%-0.01
-112.00%-0.03
-771.88%-6.45
-103.70%-0.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 33.26%122.06M-9.70%85.24M-45.05%41.14M-20.63%351.41M-22.98%90.55M-19.47%91.59M-12.09%94.4M-28.05%74.88M7.83%442.74M9.66%117.55M
Operating revenue 33.26%122.06M-9.70%85.24M-45.05%41.14M-20.63%351.41M-22.98%90.55M-19.47%91.59M-12.09%94.4M-28.05%74.88M7.83%442.74M9.66%117.55M
Cost of revenue
Gross profit
Operating expense -32.70%44.38M-40.36%40.17M-18.49%51.69M-6.82%255.69M-20.66%58.98M-4.48%65.94M-22.64%67.35M44.25%63.42M71.22%274.4M91.43%74.34M
Selling and administrative expenses -39.33%21.91M-54.56%16.8M-35.49%24.26M-8.87%144.27M-13.13%33.59M0.19%36.11M-29.57%36.96M20.85%37.61M36.48%158.31M36.20%38.67M
Research and development costs -24.67%22.47M-23.08%23.37M6.26%27.43M-4.02%111.42M-28.83%25.39M-9.57%29.83M-12.11%30.39M100.94%25.82M162.25%116.09M241.53%35.68M
Operating profit 202.84%77.68M66.66%45.07M-192.07%-10.55M-43.14%95.72M-26.95%31.56M-42.62%25.65M33.08%27.04M-80.94%11.46M-32.76%168.34M-36.79%43.21M
Net non-operating interest income expense 9.23%-7.5M-23.55%-7.54M-18.79%-7.2M-974.72%-28.57M-12.55%-8.14M-2.18%-8.27M-188.20%-6.1M-205.52%-6.06M-239.67%-2.66M-284.41%-7.23M
Non-operating interest income -19.27%930K-40.25%818K-25.66%869K-76.45%4.47M-34.84%778K-34.10%1.15M-84.37%1.37M-83.92%1.17M99.67%18.97M-78.08%1.19M
Non-operating interest expense -10.46%8.43M11.86%8.36M15.77%7.9M52.73%33.03M5.83%8.91M-4.27%9.42M305.98%7.47M506.49%6.82M184.67%21.63M182.75%8.42M
Total other finance cost ---------58.09%171K----------------1.49%408K--------
Other net income (expense) -13,400.00%-2.16M113.98%289K-4,138.44%-18.52M99.82%-1.95M110.09%567K99.66%-16K99.81%-2.07M-2,400.00%-437K-612,048.90%-1.11B-31,127.78%-5.62M
Gain on sale of security ---------------------------------89.56%19K--0
Special income (charges) -13,650.00%-2.2M112.09%250K-4,146.91%-18.56M99.77%-2.59M98.70%-73K99.66%-16K99.81%-2.07M---437K---1.11B---5.62M
-Less：Restructuring and merger&acquisition 13,650.00%2.2M-112.09%-250K4,146.91%18.56M-85.84%2.59M-88.24%73K-99.66%16K-84.11%2.07M--437K--18.32M--621K
-Less:Other special charges ----------------------------------1.1B--5M
Other non- operating income (expenses) --40K--39K--37K--640K------------------------
Income before tax 291.62%68.02M100.37%37.82M-831.59%-36.27M106.88%65.2M-20.97%24M-45.61%17.37M101.75%18.88M-92.47%4.96M-475.59%-948.07M-57.99%30.36M
Income tax 103.60%27.94M-27.93%14.22M-87.79%1.11M-22.96%64.32M-32.29%21.74M-23.68%13.72M48.88%19.74M-54.73%9.12M7.93%83.49M37.21%32.11M
Net income 999.29%40.08M2,844.07%23.6M-798.27%-37.39M100.09%880K229.28%2.26M-73.86%3.65M99.92%-860K-109.10%-4.16M-689.24%-1.03B-103.57%-1.75M
Net income continuous Operations 999.29%40.08M2,844.07%23.6M-798.27%-37.39M100.09%880K229.28%2.26M-73.86%3.65M99.92%-860K-109.10%-4.16M-689.24%-1.03B-103.57%-1.75M
Minority interest income 0000-29.32M-658K
Net income attributable to the parent company 999.29%40.08M2,844.07%23.6M-798.27%-37.39M100.09%880K307.54%2.26M-76.20%3.65M99.92%-860K-109.10%-4.16M-672.50%-1B-102.22%-1.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 999.29%40.08M2,844.07%23.6M-798.27%-37.39M100.09%880K307.54%2.26M-76.20%3.65M99.92%-860K-109.10%-4.16M-672.50%-1B-102.22%-1.09M
Basic earnings per share 1,150.00%0.251,600.00%0.15-666.67%-0.23100.16%0.01300.00%0.02-80.00%0.0299.85%-0.01-110.00%-0.03-670.80%-6.45-103.13%-0.01
Diluted earnings per share 1,050.00%0.231,500.00%0.14-666.67%-0.23100.16%0.01300.00%0.02-77.78%0.0299.85%-0.01-112.00%-0.03-771.88%-6.45-103.70%-0.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -